<DOC>
	<DOCNO>NCT01756911</DOCNO>
	<brief_summary>Evaluation Multilayer Flow Modulator ( MFM ) Endovascular Thoracoabdominal Aneurysm Repair . The objective study determine efficacy , safety performance MFM delivery system patient high surgical risk present type II , III thoracoabdominal aneurysm , leave subclavian iliac bifurcation , accord Crawford classification .</brief_summary>
	<brief_title>Evaluation Safety Efficacy Multilayer Stent</brief_title>
	<detailed_description>Conventional treatment thoracoabdominal aneurysm medical treatment ( base hypertension control ) one hand surgical treatment hand . The standard treatment surgery consist exclusion aneurysm restoration continuity mean prosthesis usually make Dacron . - The rate surgical morbidity mortality differ accord whether patient treat electively emergency set . The feared complication spinal cord ischemia induce paraplegia . - In elective surgery , operative mortality estimate 6 % 15 % depend series , around 50 % 60 % patient treated emergency set . The rate neurological complication paraparesis paraplegia estimate 3 % 15 % . - In addition , follow major complication show impact morbidity major surgery ( 5 % ) : - Bleeding require surgical hemostasis - Respiratory distress syndrome require prolonged ventilation support - Acute renal failure - Infections - Central neurological event ( stroke coma ) - Peripheral neurological event ( sensory-motor deficit , paraparesis , paraplegia ) Analyses identify risk factor increase morbidity mortality : - Patients 80 year - Chronic obstructive pulmonary disease - Renal failure - Coronary artery disease - Comorbidities ( malignancy , etc . ) Compared surgery , endovascular stenting reduces : - Pulmonary morbidity ( suppression thoracotomy ventilation ) , patient impair lung function ; - Renal dysfunction ; - Myocardial failure ; - Risk spinal cord ischemia paraplegia . However , treatment number limitation - Availability device case emergency - Topography neck must far enough left subclavian artery allow satisfactory fixation stent exclusion lesion ; - Obstruction branch near aneurysm . In current available treatment pathology , still disadvantage difficulty precise position prosthesis branch must cover aneurysm tissue without endoleaks . Each lesion anatomical specificity , device must design individual patient , operator 's technical ability must extreme . So , current technique difficult reproduce , emergency treatment impossible . The multilayer flow modulator ( non-covered ) device use trial The complication mention inherent concept cover stent treatment plus endoleaks continue fuel aneurismal sac untreated , thus subject persistent risk rupture . With technique , visceral artery occlude retrograde flow ( pressurizes aneurysm ) . The multilayer flow modulator ( non-covered ) treatment approach avoids major problem mention : - It allow aneurismal sac thrombose whilst maintain patency collateral branch arise aneurysm ; - It improve flow collateral branch , become laminar flow mechanism hemodynamic pressure drop layer layer increase speed roll ; - Deployment easy different peripheral stent deployment ; - The device available sizes length store , allow management emergency . The space-age 3D geometrical design Cardiatis multilayer flow modulator modifies flow within aorta way reduces pressure within aneurysm thus collapse aneurismal sac preserve vital collateral circulation .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm</mesh_term>
	<mesh_term>Aortic Aneurysm , Thoracic</mesh_term>
	<criteria>Age &gt; 18 year Life expectancy ≥ 12 month The patient legal representative sign informed consent form Thoracoabdominal aneurysm type 2 3 vital collateral require intervention prevent rupture accord criterion define consensus ( `` Expert Consensus Document Treatment Descending Thoracic Aortic Disease Using Endovascular StentGrafts '' , Ann Thorac Surg 2008 ; 85 : S141 ) Contraindicated open surgery , declare inoperable surgeon anesthetist ( statement sign doctor ) must least one follow : 1 . Age &gt; 80 year 2 . ASA ( American Society Anesthesiologists ) score ≥ 3 3 . History thoracic surgery surgery abdominal aorta 4 . Coronary artery disease ( history angina myocardial infarction ) positive functional test coronary lesion revascularization impossible indicate 5 . Heart failure 6 . Inoperable aortic stenosis 7 . LVEF ( Left Ventricular Ejection Fraction ) &lt; 40 % ; 8. chronic respiratory failure define one follow criterion : 1 . FEV ( Forced expiratory volume ) &lt; 1.2 l / sec ; 2 . VC ( Vital Capacity ) &lt; 50 % predict value accord age , sex weight ; 3. arterial blood gas analysis absence oxygen : PaCO2 ( Pression artérielle en CO2 ) &gt; 45 mmHg PaO2 ( Pression artérielle en O2 ) &lt; 60 mmHg 4 . Oxygen therapy 9. renal insufficiency creatininaemia &gt; 200 micromol / l injection contrast product ; 10. hostile abdomen , include presence ascites sign portal hypertension ; 11. obesity . adequate arterial anatomy aneurismal lesion access . medical contraindication local general anesthesia angiography ; Life expectancy less one year , clinical followup impossible ; congenital disorder blood coagulation ; intercurrent infection ; allergy aspirin , clopidogrel , contrast agent ; patient ( ) include another clinical study ; patient pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>MFM</keyword>
	<keyword>Multilayer Flow Modulator</keyword>
	<keyword>Multilayer stent</keyword>
	<keyword>Thoracoabdominal Aortic Aneurysm</keyword>
</DOC>